May 5, 2026 04:05PM
Feb 25, 2026 04:05PM
Jan 12, 2026 08:31AM
Jan 12, 2026 08:30AM
Dec 9, 2025 11:57AM
Nov 5, 2025 04:05PM
Aug 6, 2025 04:05PM Schrödinger Reports Second Quarter 2025 Financial Results
Jun 27, 2025 08:04AM
Jun 27, 2025 08:00AM
Jun 12, 2025 07:00AM
May 7, 2025 04:05PM
Apr 14, 2025 08:00AM
Apr 14, 2025 08:00AM
Feb 26, 2025 04:05PM Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results
Jan 13, 2025 07:00AM
Jul 31, 2024 04:05PM
Jul 26, 2024 07:00AM
May 1, 2024 04:00PM
Jan 8, 2024 07:30AM
Dec 14, 2023 07:04AM
Dec 14, 2023 07:04AM Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event
Nov 1, 2023 04:00PM
Aug 2, 2023 04:00PM
Jan 9, 2023 07:00AM
Dec 12, 2022 07:00AM
Aug 4, 2022 04:00PM
Jun 28, 2022 07:01AM
Jun 28, 2022 07:00AM Schrödinger Announces FDA Clearance of Investigational New Drug Application for SGR-1505, a MALT1 Inhibitor
May 4, 2022 04:01PM
Apr 12, 2022 07:02AM
Apr 12, 2022 07:00AM
Dec 13, 2021 05:18AM
Dec 11, 2021 09:05AM
Nov 10, 2021 04:01PM
Aug 12, 2021 07:01AM Schrödinger Reports Second Quarter 2021 Financial Results and Provides Company Update
May 11, 2021 07:01AM
Aug 11, 2020 09:30AM
Aug 10, 2020 06:16PM
Jul 19, 2020 08:00PM
Jul 19, 2020 07:05PM
Feb 21, 2020 09:12AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All